EliKine™ Human CEA ELISA Kit: The Gold Standard for Tumor Marker Quantification
CEA: The Most Widely Used Tumor Marker in Clinical Oncology
Carcinoembryonic antigen (CEA) is a complex immunoreactive glycoprotein that serves as one of the most widely used tumor markers in clinical oncology[reference:77]. It is primarily employed for monitoring colorectal cancer treatment response, detecting recurrence, and assessing prognosis. Beyond colorectal cancer, elevated CEA levels are also observed in lung, breast, pancreatic, and gastric cancers.
Why Abbkine KTE6038 Leads the Field
| Feature | Abbkine KTE6038 | Alternative CEA Assays |
|---|---|---|
| Detection Format | Double antibody sandwich ELISA[reference:78] | Variable |
| Sample Types | Serum, plasma, tissue homogenates, biological fluids[reference:79] | Limited |
| Specificity | High; no cross-reactivity with analogues[reference:80] | Variable |
| Throughput | 96-well microplate | Lower |
| Reliability | Precision-engineered for human CEA[reference:81] | Varies |
| Validation | Validated for tumor monitoring research[reference:82] | Varies |
The Double Antibody Sandwich Advantage
The EliKine™ Human CEA ELISA Kit employs a double antibody sandwich method to quantitate Human CEA in samples[reference:83]. At its core, the kit uses two highly specific antibodies: a pre-coated capture antibody and a biotin-conjugated detection antibody[reference:84]. This dual-antibody approach ensures exceptional specificity and minimizes background noise.
Why CEA Matters in Your Research
CEA is essential for:
- Colorectal cancer monitoring — tracking treatment response and detecting recurrence[reference:85]
- Prognostic assessment — elevated CEA correlates with poor outcomes
- Translational research — bridging preclinical models to clinical applications[reference:86]
- Therapeutic efficacy evaluation — monitoring response to chemotherapy and targeted therapy
Sample Compatibility
The kit is validated for quantitative determination of CEA concentrations in:
- Serum and plasma[reference:87]
- Tissue homogenates[reference:88]
- Other biological fluids[reference:89]
The Bottom Line
For researchers conducting tumor monitoring studies, translational oncology research, or therapeutic efficacy evaluation, KTE6038 delivers the reliability, specificity, and performance that CEA quantification demands. The double antibody sandwich design ensures you get accurate data—not noise[reference:90].
👉 Quantify CEA with confidence. View Product
